One in three people non-adherent with DPP-4 inhibitor therapy within a year

About 1 in 3 people newly prescribed DPP-4 inhibitors will be non-adherent or stop taking the drug altogether within a year, Australian figures show. A review of PBS data for almost 16,000 people with type 2 diabetes found that 36% were non-adherent (taking less than 80% of the prescribed doses) and 30% were non-persistent (discontinued ...

Already a member?

Login to keep reading.

© 2021 the limbic